Literature DB >> 20119682

Diabetic ketoacidosis in type 2 diabetics: a novel presentation of pancreatic adenocarcinoma.

Ming Valerie Lin1, Gene Bishop, Maria Benito-Herrero.   

Abstract

Diabetic ketoacidosis (DKA) has been the hallmark of a life-threatening medical emergency for poorly controlled or newly diagnosed type 1 diabetics. In the last two decades, this traditional association has been challenged with increasing reports of type 2 diabetics presenting with DKA. We report the case of a 75-year-old woman with known type 2 diabetes who presented in DKA and was found to have pancreatic adenocarcinoma. A link between diabetes mellitus and pancreatic cancer has been investigated, but the literature remains inconclusive as to whether diabetes mellitus (DM) is a cause or result of pancreatic cancer or simply the confluence of two common entities. Previous case reports of pancreatic tumors presenting with DKA all represented neuroendocrine tumors. Adenocarcinoma of the pancreas should be considered in the list of precipitants for DKA in type 2 DM.

Entities:  

Mesh:

Year:  2010        PMID: 20119682      PMCID: PMC2842543          DOI: 10.1007/s11606-009-1237-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  27 in total

1.  The intracellular mechanism of insulin resistance in pancreatic cancer patients.

Authors:  J Liu; J A Knezetic; L Strömmer; J Permert; J Larsson; T E Adrian
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

2.  Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin.

Authors:  P M Pour; K Stepan
Journal:  J Natl Cancer Inst       Date:  1984-05       Impact factor: 13.506

Review 3.  Glucolipotoxicity of the pancreatic beta-cell: myth or reality?

Authors:  Vincent Poitout
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

4.  Beta-cell function in pancreatic adenocarcinoma.

Authors:  D Basso; M Plebani; P Fogar; G Del Favero; G Briani; T Meggiato; M P Panozzo; C Ferrara; F D'Angeli; A Burlina
Journal:  Pancreas       Date:  1994-05       Impact factor: 3.327

5.  Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?

Authors:  J Permert; T E Adrian; P Jacobsson; L Jorfelt; A B Fruin; J Larsson
Journal:  Am J Surg       Date:  1993-01       Impact factor: 2.565

6.  Insulin secretion and action in patients with pancreatic cancer.

Authors:  E Cersosimo; P W Pisters; G Pesola; K McDermott; D Bajorunas; M F Brennan
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

7.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Authors:  S Bonner-Weir; D F Trent; G C Weir
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

8.  Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulation.

Authors:  J N Fox; B M Frier; M Armitage; J P Ashby
Journal:  Diabet Med       Date:  1985-03       Impact factor: 4.359

9.  High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey.

Authors:  Mustafa Cetin; Ramiz Colak; Fahri Bayram; Mustafa Altinbaş; Ali Unal; Fahrettin Keleştimur
Journal:  Diabetes Res Clin Pract       Date:  2002-11       Impact factor: 5.602

Review 10.  The relationship between diabetes and pancreatic cancer.

Authors:  Feng Wang; Margery Herrington; Jörgen Larsson; Johan Permert
Journal:  Mol Cancer       Date:  2003-01-06       Impact factor: 27.401

View more
  4 in total

1.  The nutritional phenome of EMT-induced cancer stem-like cells.

Authors:  Elisabet Cuyàs; Bruna Corominas-Faja; Javier A Menendez
Journal:  Oncotarget       Date:  2014-06-30

2.  Diabetic ketoacidosis as the presenting manifestation of pancreatic adenocarcinoma with cystic features.

Authors:  Tezcan Kaya; Sumeyye Korkmaz; Erdem Vargol; Alper Karacan; Hakan Cinemre
Journal:  Turk J Emerg Med       Date:  2016-05-29

Review 3.  The bidirectional interation between pancreatic cancer and diabetes.

Authors:  Junhui Li; Gang Cao; Qingyong Ma; Han Liu; Wei Li; Liang Han
Journal:  World J Surg Oncol       Date:  2012-08-24       Impact factor: 2.754

4.  Diabetic ketoacidosis as a presenting symptom of complicated pancreatic cancer.

Authors:  Kyung Ae Lee; Kyung Taek Park; Woong Ji Kim; Tae Sun Park; Hong Sun Baek; Heung Yong Jin
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.